Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors

Cancer Immunology, Immunotherapy

Volumn 57, Issue 11, 2008, Pages 1695-1703

  Cho, Hyun Il ^a   Niu, Guilian ^a   Bradley, Norma ^a   Celis, Esteban ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Animal models; Breast cancer; CD8 T cells; DNA vaccines; HER2 neu

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTINEOPLASTIC ACTIVITY; BREAST TUMOR; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; DNA IMMUNIZATION; EMBRYO; FEMALE; MOUSE; NONHUMAN; ONCOGENE NEU; PLASMID; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOMA, LOBULAR; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

EID: 50649084152     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0465-x     Document Type: Conference Paper

References (17)

1. C Buteau SN Markovic E Celis 2002 Challenges in the development of effective peptide vaccines for cancer Mayo Clinic Proc 77 339 349
2. C Guy M Webster M Schaller T Parsons R Cardiff W Muller 1992 Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc Natl Acad Sci USA 89 10578 10582
3. F Lucchini MG Sacco N Hu A Villa J Brown L Cesano L Mangiarini G Rindi S Kindl F Sessa 1992 Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice Cancer Lett 64 203 209
4. K Boggio G Nicoletti E Di Carlo F Cavallo L Landuzzi C Melani M Giovarelli I Rossi P Nanni C De Giovanni P Bouchard S Wolf A Modesti P Musiani PL Lollini MP Colombo G Forni 1998 Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice J Exp Med 188 589 596
5. E Quaglino M Iezzi C Mastini A Amici F Pericle E Di Carlo SM Pupa C De Giovanni M Spadaro C Curcio PL Lollini P Musiani G Forni F Cavallo 2004 Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice Cancer Res 64 2858 2864
6. S Rovero A Amici ED Carlo R Bei P Nanni E Quaglino P Porcedda K Boggio A Smorlesi PL Lollini L Landuzzi MP Colombo M Giovarelli P Musiani G Forni 2000 DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice J Immunol 165 5133 5142
7. P Nava-Parada G Forni KL Knutson LR Pease E Celis 2007 Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors Cancer Res 67 1326 1334
8. LB RX Lachman RH Kremer B Ozpolat G Kiriakova JE Price 2001 DNA vaccination against neu reduces breast cancer incidence and metastasis in mice Cancer Gene Ther 8 259 268
9. FR Miller BE Miller GH Heppner 1983 Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability Invasion Metastasis 3 22 31
10. M Spadaro E Ambrosino M Iezzi E Di Carlo P Sacchetti C Curcio A Amici WZ Wei P Musiani PL Lollini F Cavallo G Forni 2005 Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity Clin Cancer Res 11 1941 1952
11. R Shimonkevitz J Kappler P Marrack H Grey 1983 Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing J Exp Med 158 303 316
12. MP Piechocki SA Pilon WZ Wei 2002 Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA J Immunol Methods 259 33 42
13. M Spadaro E Ambrosino M Iezzi E Di Carlo P Sacchetti C Curcio A Amici W-Z Wei P Musiani P-L Lollini F Cavallo G Forni 2005 Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity Clin Cancer Res 11 1941 1952
14. P Gallo S Dharmapuri M Nuzzo D Maldini B Cipriani G Forni P Monaci 2007 Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice Int J Cancer 120 574 584
15. S Rolla C Nicolo S Malinarich M Orsini G Forni F Cavallo F Ria 2006 Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice J Immunol 177 7626 7633
16. C Curcio E Di Carlo R Clynes MJ Smyth K Boggio E Quaglino M Spadaro MP Colombo A Amici PL Lollini P Musiani G Forni 2003 Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas J Clin Invest 111 1161 1170
17. JL Whitton N Sheng MB Oldstone TA McKee 1993 A "string-of- beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge J Virol 67 348 352